findmyKOL
Clinical trialNCT03249376CompletedPhase 3Interventional

Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally

SponsorIntra-Cellular Therapies, Inc.Enrollment381Bipolar Depression
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Bulgaria
  • Clinical Site

    Burgas, Bulgaria

  • Clinical Site

    Kardzhali, Bulgaria

  • Clinical Site

    Lovech, Bulgaria

  • Clinical Site

    Plovdiv, Bulgaria

  • Clinical Site

    Rousse, Bulgaria

  • Clinical Site

    Sofia, Bulgaria

  • Clinical Site

    Targovishte, Bulgaria

  • Clinical Site

    Tsarev Brod, Bulgaria

  • Clinical Site

    Varna, Bulgaria

  • Clinical Site

    Veliko Tarnovo, Bulgaria

Colombia
  • Clinical Site

    Barranquilla, Colombia

  • Clinical Site

    Bello, Colombia

  • Clinical Site

    Pereira, Colombia

Russia
  • Clinical Site

    Moscow, Russia

  • Clinical Site

    Nizhny Novgorod, Russia

  • Clinical Site

    Omsk, Russia

  • Clinical Site

    Saint Petersburg, Russia

  • Clinical Site

    Samara, Russia

  • Clinical Site

    Saratov, Russia

  • Clinical Site

    Tomsk, Russia

  • Clinical Site

    Yekaterinburg, Russia

Serbia
  • Clinical Site

    Belgrade, Serbia

  • Clinical Site

    Kragujevac, Serbia

  • Clinical Site

    Novi Sad, Serbia

Ukraine
  • Clinical Site

    Ivano-Frankivsk, Ukraine

  • Clinical Site

    Kharkiv, Ukraine

  • Clinical Site

    Kherson, Ukraine

  • Clinical Site

    Lviv, Ukraine

  • Clinical Site

    Odesa, Ukraine

  • Clinical Site

    Poltava, Ukraine

  • Clinical Site

    Smila, Ukraine

  • Clinical Site

    Uzhhorod, Ukraine

  • Clinical Site

    Vinnytsia, Ukraine

United States
  • Clinical Site

    Birmingham, Alabama, United States

  • Clinical Site

    Sherman Oaks, California, United States

  • Clinical Site

    Miami, Florida, United States

  • Clinical Site

    Orange City, Florida, United States

  • Clinical Site

    Atlanta, Georgia, United States

  • Clinical Site

    Decatur, Georgia, United States

  • Clinical Site

    Chicago, Illinois, United States

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Nov 2017
Primary completion
1 Mar 2019
Completion
1 Mar 2019
Last update posted
3 Jun 2022
Registered enrollment
381
Registry id
NCT03249376

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.